Joe Bonaccorso
Corporate Officer/Principal at VERRICA PHARMACEUTICALS INC.
Net worth: 783 761 $ as of 31/03/2024
Profile
Joe Bonaccorso is currently the Chief Commercial Officer at Verrica Pharmaceuticals, Inc. He previously worked as a Principal at Novartis Pharmaceuticals Corp.
Mr. Bonaccorso completed his undergraduate degree at Fairleigh Dickinson University in 1985 and obtained an MBA from Kean University in 1993.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 15/03/2024 | 132,392 ( 0.31% ) | 783 761 $ | 31/03/2024 |
Joe Bonaccorso active positions
| Companies | Position | Start |
|---|---|---|
| VERRICA PHARMACEUTICALS INC. | Corporate Officer/Principal | 01/02/2018 |
Former positions of Joe Bonaccorso
| Companies | Position | End |
|---|---|---|
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | - |
Training of Joe Bonaccorso
| Fairleigh Dickinson University | Undergraduate Degree |
| Kean University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| VERRICA PHARMACEUTICALS INC. | Health Technology |
| Private companies | 1 |
|---|---|
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
- Stock Market
- Insiders
- Joe Bonaccorso
